Labcyte was acquired by Beckman Coulter Life Sciences in January 2019, and Echo liquid handlers and Access workstations are now part of the Beckman Coulter Life Sciences Biotechnology business unit.
Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality control experts and others. From prestigious universities and major pharmaceutical companies, to small biotech startups, food/beverage and electronics manufacturing facilities, you can find our name virtually everywhere. For more details, visit beckman.com.
Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality control experts and others. From prestigious universities and major pharmaceutical companies, to small biotech startups, food/beverage and electronics manufacturing facilities, you can find our name virtually everywhere. For more details, visit beckman.com.
Location: United States, California, San Jose
Employees: 10001+
Founded date: 1935
Mentions in press and media 9
Date | Title | Description |
13.03.2025 | T-NeuroDx and Beckman Coulter Life Sciences to Collaborate on Early Alzheimer's Disease Research | T-Neuro Dx This collaboration represents a significant step forward in our mission to advance early detection of Alzheimer’s disease,” — Kristina Trujillo, Ph.D. and CEO of T-NeuroDxALBUQUERQUE, NM, UNITED STATES, March 13, 2025 /EINPresswi... |
04.11.2024 | 8 Things We Learned at the Future of Protein Production Event in Amsterdam | 6 Mins Read “Change starts here,” Ira Van Eelen, co-founder at KindEarth.Tech and RESPECTfarms noted on the opening day of the Future of Protein Production Amsterdam 2024. With over 500 delegates, 45 exhibitors, and two packed days of panel... |
03.09.2024 | Next Generation Sequencing Market is poised to grow from USD 36.04 billion by 2031: Skyquest Technology | Share Tweet Share Share Email In recent years, next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS i... |
30.07.2024 | Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease | The collaboration aims to identify and develop accessible, minimally invasive blood-based biomarkers specific for tau pathology in the brain These tools have the potential to be used to stratify patients or monitor treatment response for a ... |
15.05.2023 | Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance | DxI 9000 Access Immunoassay Analyzer Boasts Industry's Highest Throughput per Footprint: Up To 215 Tests/Hour/Square Meter Innovations Bolster Assay Performance and Laboratory Productivity with New Analyte Processing and Detection Technolog... |
31.03.2022 | Premas Life Sciences Continues to Take Indian Research to New Avenues with its Strategic Partnerships | New Delhi, Delhi, India Premas Life Sciences (PLS) and Beckman Coulter today announced a new sales distribution agreement, appointing Premas Life Sciences as the technology and knowledge partner of Beckman Coulter Life Sciences Automated Li... |
15.09.2021 | Beckman Coulter Life Sciences Debuts The Future Of Simplified PCR Cleanup And Plasmid Prep With The EMnetik System | |
- | High-Tech Gründerfonds: Successful sale of portfolio company m2p-labs GmbH to Beckman Coulter Life Sciences | Together with lead investor FIDURA, KfW Development Bank, TechVision Fonds and other co-investors, High-Tech Gründerfonds (HTGF) has successfully sold its shares in m2p-labs GmbH, one of the leading manufacturers of microbioreactors, to Bec... |
- | Labcyte Sold to Beckman Coulter. | Dublin, Ireland. 30 January 2019. Seroba portfolio company, Labcyte, has been acquired by Beckman Coulter Life Sciences, part of the larger Danaher Corporation which generates approximately $6.5 billion in annual revenue. Labcyte is best k... |